A detailed history of Quadrant Capital Group LLC transactions in Organon & Co. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 18,347 shares of OGN stock, worth $280,892. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,347
Previous 18,982 3.35%
Holding current value
$280,892
Previous $392,000 10.71%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.65 - $23.03 $11,842 - $14,624
-635 Reduced 3.35%
18,347 $350,000
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $16,088 - $20,247
922 Added 5.11%
18,982 $392,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $90,892 - $124,004
6,596 Added 57.54%
18,060 $339,000
Q4 2023

Feb 08, 2024

BUY
$10.95 - $17.32 $116,037 - $183,540
10,597 Added 1222.26%
11,464 $165,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $3,666 - $5,253
-221 Reduced 20.31%
867 $15,000
Q2 2023

Aug 09, 2023

SELL
$19.27 - $24.63 $3,622 - $4,630
-188 Reduced 14.73%
1,088 $22,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $5,247 - $7,859
245 Added 23.76%
1,276 $30,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $5,011 - $6,151
-215 Reduced 17.26%
1,031 $28,000
Q3 2022

Nov 10, 2022

SELL
$23.4 - $34.25 $4,843 - $7,089
-207 Reduced 14.25%
1,246 $29,000
Q2 2022

Aug 09, 2022

SELL
$31.66 - $38.9 $6,490 - $7,974
-205 Reduced 12.36%
1,453 $49,000
Q1 2022

May 06, 2022

BUY
$30.45 - $39.36 $669 - $865
22 Added 1.34%
1,658 $58,000
Q4 2021

Feb 01, 2022

BUY
$28.67 - $37.13 $430 - $556
15 Added 0.93%
1,636 $50,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $7,815 - $9,729
-273 Reduced 14.41%
1,621 $53,000
Q2 2021

Aug 09, 2021

BUY
$28.45 - $38.0 $53,884 - $71,972
1,894 New
1,894 $57,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.